The Latin America, Middle East and Africa L-Carnitine Market would witness market growth of 5.97% CAGR during the forecast period (2019-2025).
L-carnitine supplements are used to improve the lactation rate in cows. In addition, for growing sheep, oral administration of L-carnitine is recommended to increase concentrations of plasma glucose. Consistent use of L-carnitine supplements, however, has been shown to have positive effects on growth efficiency, carcass composition, and pig breeding. Changing the elderly population's eating habits also leads to low appetite and lower levels of energy. The reduction in nutritious food consumption results in decreased dietary intake of both L-carnitine and L-carnitine nutrients. This reduction in energy metabolism can be reversed with L-carnitine supplementation because of the low levels of L-carnitine.
Recent studies suggest that the use of L-carnitine may be a significant contributor to the advancement of neuropathy treatments. It is also a highly advantageous health protection agent. Therefore, the global market's leading players are focused on developing new and more specialized innovations that can help determine the value of L-carnitine in the global healthcare industry. The next few years with L-carnitine are expected to be a period of new and fresh technologies with rising research and development. This trend is expected to facilitate the growth of the global market.
Based on Product, the market is segmented into Food & Pharma Grade and Feed Grade. Based on Process, the market is segmented into Chemical Synthesis and Bioprocess. Based on Application, the market is segmented into Healthcare Product, Functional Drink, Medicine and Animal Food. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: L-Carnitine Market in LAMEA is expected to register a CAGR of 5.97% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
Market Segmentation:
By Product
By Process
By Application
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
